Forbes C D, McNicol G P, Douglas A S
Br Med J. 1969 May 24;2(5655):483-5. doi: 10.1136/bmj.2.5655.483.
A pyrimido-pyrimidine compound (RA433) was found in vitro to be a significantly more potent inhibitor of platelet behaviour than the previously available pyrimido-pyrimidine compound RA8-dipyridamole. In a turbidimetric system RA433 inhibits platelet aggregation induced by adenosine diphosphate, collagen, and noradrenaline; further, in a glass-bead-column technique it is a powerful inhiitor of platelet adhesiveness.
一种嘧啶并嘧啶化合物(RA433)在体外被发现是一种比之前可用的嘧啶并嘧啶化合物RA8-双嘧达莫更有效的血小板行为抑制剂。在比浊法系统中,RA433可抑制由二磷酸腺苷、胶原蛋白和去甲肾上腺素诱导的血小板聚集;此外,在玻璃珠柱技术中,它是血小板黏附的强力抑制剂。